All In MedTech

FDA Clearance Tracker · P180031-S012

Neuroform Atlas® Stent System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 24, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P180031-S012
Device name
Neuroform Atlas® Stent System
Applicant location
Fremont, CA
Received
Mar 4, 2026
Decided
Oct 24, 2026
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P180031

Device type

Device class
Class III

Every decision under product code QCA

FDA's approval statement

As written in FDA's record.

approval for a manufacturing site located at Nitinol Devices and Components Costa Rica, S.R.L., Building B28, El Coyol, Alajuela 20102 Costa Rica for the postlaser cutting operations of the Neuroform Atlas stent component

Source documents

Other decisions for Stryker Neurovascular

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.